MiMedx Group (MDXG) Current Ratio: History & Chart

MiMedx Group, Inc.(MDXG)

Biotechnology · Marietta, GA

$4.62+0.07 (+1.54%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About MiMedx Group, Inc.

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.

Marietta, GA

808 employees

www.mimedx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joseph H. Capper

View full financials

MDXG Current Ratio Metrics

CURRENT RATIO

5.33

CURRENT RATIO AVG TTM

4.77

CURRENT RATIO AVG 3Y

4.18

CURRENT RATIO AVG 5Y

3.84

CURRENT RATIO AVG 10Y

2.85

CURRENT RATIO AVG 15Y

3.06

CURRENT RATIO AVG 20Y

2.72

CURRENT VS TTM AVG

+11.86%

CURRENT VS 3Y AVG

+27.76%

CURRENT VS 5Y AVG

+38.96%

CURRENT VS 10Y AVG

+87.38%

CURRENT VS 15Y AVG

+74.28%

CURRENT VS 20Y AVG

+96.46%

SECTOR MEDIAN · HEALTHCARE

3.76

median of 873 covered companies

CURRENT VS SECTOR MEDIAN

+41.87%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
MiMedx Group, Inc. (MDXG)	$673.41M	5.33	4.77	4.18	3.84
Helus Pharma Inc. (HELP)vs ›	$666.95M	10.97	8.63	10.75	10.66
Verastem, Inc. (VSTM)vs ›	$681.02M	2.25	3.08	3.98	5.01
Solid Biosciences Inc. (SLDB)vs ›	$681.27M	13.82	5.67	7.51	7.66
Anteris Technologies Global Corp. (AVR)vs ›	$685.49M	14.20	2.62	2.46	2.12
Annexon, Inc. (ANNX)vs ›	$660.29M	5.53	8.02	10.47	14.43
Starling Oncology, Inc. (STLN)vs ›	$657.89M	1.36	1.59	1.59	1.59
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$656.59M	8.03	12.16	13.50	14.42
Olema Pharmaceuticals, Inc. (OLMA)vs ›	$691.79M	8.86	10.22	11.35	25.38
Faeth Therapeutics, Inc. (FTH)vs ›	$693.19M	19.69	6.38	9.16	11.87

NAME

MARKET CAP

CURRENT RATIO

TTM

MiMedx Group, Inc. (MDXG)

$673.41M

5.33

4.77

4.18

3.84

Helus Pharma Inc. (HELP)vs ›

$666.95M

10.97

8.63

10.75

10.66

Verastem, Inc. (VSTM)vs ›

$681.02M

2.25

3.08

3.98

5.01

Solid Biosciences Inc. (SLDB)vs ›

$681.27M

13.82

5.67

7.51

7.66

Anteris Technologies Global Corp. (AVR)vs ›

$685.49M

14.20

2.62

2.46

2.12

Annexon, Inc. (ANNX)vs ›

$660.29M

5.53

8.02

10.47

14.43

Starling Oncology, Inc. (STLN)vs ›

$657.89M

1.36

1.59

4D Molecular Therapeutics, Inc. (FDMT)vs ›

$656.59M

8.03

12.16

13.50

14.42

Olema Pharmaceuticals, Inc. (OLMA)vs ›

$691.79M

8.86

10.22

11.35

25.38

Faeth Therapeutics, Inc. (FTH)vs ›

$693.19M

19.69

6.38

9.16

11.87

Current Ratio FAQ

What is the current ratio for MiMedx Group, Inc. (MDXG)?

The current ratio for MDXG stock is 5.33.

Is MiMedx Group, Inc.'s current ratio high or low?

The current ratio of 5.33 is 39% above its 5-year average of 3.84, near the high end of its 5-year range (2.92–5.39).

What is the TTM average current ratio for MiMedx Group, Inc. (MDXG)?

The TTM average current ratio for MDXG stock is 4.77.

What is the 3Y average current ratio for MiMedx Group, Inc. (MDXG)?

The 3Y average current ratio for MDXG stock is 4.18.

What is the 5Y average current ratio for MiMedx Group, Inc. (MDXG)?

The 5Y average current ratio for MDXG stock is 3.84.

What is the 10Y average current ratio for MiMedx Group, Inc. (MDXG)?

The 10Y average current ratio for MDXG stock is 2.85.

What is the 15Y average current ratio for MiMedx Group, Inc. (MDXG)?

The 15Y average current ratio for MDXG stock is 3.06.

What is the 20Y average current ratio for MiMedx Group, Inc. (MDXG)?

The 20Y average current ratio for MDXG stock is 2.72.

DATE	CURRENT RATIO
2026-06-30	5.33
2026-03-31	5.39
2025-12-31	4.32
2025-09-30	4.41
2025-06-30	4.39
2025-03-31	4.70
2024-12-31	4.21
2024-09-30	4.10
2024-06-30	3.85
2024-03-31	3.29
2023-12-31	3.57
2023-09-30	3.54
2023-06-30	3.18
2023-03-31	3.22
2022-12-31	3.08
2022-09-30	2.97
2022-06-30	3.53
2022-03-31	3.71
2021-12-31	3.51
2021-09-30	3.40
2021-06-30	2.92
2021-03-31	2.71
2020-12-31	2.71
2020-09-30	2.99
2020-06-30	1.69
2020-03-31	1.82
2019-12-31	1.83
2019-09-30	1.83
2019-06-30	1.57
2019-03-31	0.89
2018-12-31	1.03
2018-09-30	0.00
2018-06-30	0.00
2018-03-31	0.00
2017-12-31	1.06
2017-09-30	3.25
2017-06-30	2.57
2017-03-31	2.46
2016-12-31	2.49
2016-09-30	2.56
2016-06-30	2.64
2016-03-31	3.30
2015-12-31	3.60
2015-09-30	4.22
2015-06-30	4.72
2015-03-31	4.46
2014-12-31	4.66
2014-09-30	5.35
2014-06-30	6.69
2014-03-31	7.08
2013-12-31	6.81
2013-09-30	3.10
2013-06-30	3.51
2013-03-31	3.47
2012-12-31	3.57
2012-09-30	1.53
2012-06-30	0.95
2012-03-31	1.04
2011-12-31	0.87
2011-09-30	0.44
2011-06-30	0.65
2011-03-31	0.87
2010-12-31	1.36
2010-09-30	0.81
2010-06-30	2.64
2010-03-31	2.14
2009-12-31	0.00
2009-09-30	0.10
2009-06-30	1.51
2009-03-31	0.07
2008-12-31	0.73
2008-09-30	1.57
2008-06-30	4.68
2008-03-31	7.32
2007-12-31	0.01
2007-09-30	0.08
2007-06-30	0.55
2007-03-31	0.65

DATE

CURRENT RATIO

2026-06-30

5.33

2026-03-31

5.39

2025-12-31

4.32

2025-09-30

4.41

2025-06-30

4.39

2025-03-31

4.70

2024-12-31

4.21

2024-09-30

4.10

2024-06-30

3.85

2024-03-31

3.29

2023-12-31

3.57

2023-09-30

3.54

2023-06-30

3.18

2023-03-31

3.22

2022-12-31

3.08

2022-09-30

2.97

2022-06-30

3.53

2022-03-31

3.71

2021-12-31

3.51

2021-09-30

3.40

2021-06-30

2.92

2021-03-31

2.71

2020-12-31

2.71

2020-09-30

2.99

2020-06-30

1.69

2020-03-31

1.82

2019-12-31

1.83

2019-09-30

1.83

2019-06-30

1.57

2019-03-31

0.89

2018-12-31

1.03

2018-09-30

0.00

2018-06-30

0.00

2018-03-31

0.00

2017-12-31

1.06

2017-09-30

3.25

2017-06-30

2.57

2017-03-31

2.46

2016-12-31

2.49

2016-09-30

2.56

2016-06-30

2.64

2016-03-31

3.30

2015-12-31

3.60

2015-09-30

4.22

2015-06-30

4.72

2015-03-31

4.46

2014-12-31

4.66

2014-09-30

5.35

2014-06-30

6.69

2014-03-31

7.08

2013-12-31

6.81

2013-09-30

3.10

2013-06-30

3.51

2013-03-31

3.47

2012-12-31

3.57

2012-09-30

1.53

2012-06-30

0.95

2012-03-31

1.04

2011-12-31

0.87

2011-09-30

0.44

2011-06-30

0.65

2011-03-31

0.87

2010-12-31

1.36

2010-09-30

0.81

2010-06-30

2.64

2010-03-31

2.14

2009-12-31

0.00

2009-09-30

0.10

2009-06-30

1.51

2009-03-31

0.07

2008-12-31

0.73

2008-09-30

1.57

2008-06-30

4.68

2008-03-31

7.32

2007-12-31

0.01

2007-09-30

0.08

2007-06-30

0.55

2007-03-31

0.65

Current Ratio: 5.33

MDXG Current Ratio

MDXG Average Current Ratio Chart

MDXG Current vs Average Current Ratio Chart

MDXG Current Ratio Metrics

MDXG Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

MDXG Current Ratio History

Related Metrics